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Abstract 
Introduction: The aim of periodontal treatment is to regenerate periodontium. Regenerative 
treatments include the use of plasma that is rich in growth factors (PRGF). 
Materials & Methods: In a randomized clinical trial, 20 three-walled intrabony defects from five 
patients with moderate periodontitis were randomly assigned to three groups. Patients in the 
control group underwent debridement of lesions. In the first treatment group, the defects were 
debrided and cenomembrane was applied. The third group was treated with debridement, PRGF 
and cenomembrane. Measures of vertical probing depth (VPD), vertical clinical attachment level 
(VCAL), gingival index (GI; Sinless and Loe) and radiographic index (by digital subtraction) were 
made preoperatively and 6 months post-surgery. Wilcoxon signed-ranks and Chi-square tests were 
used for analyzing quantitative and qualitative variables, respectively. 
Results: All three groups showed improvements in all measures except GI. Intra-group 
comparison for clinical attachment level (CAL) indicated significant difference in all groups 
before and after surgery (P<0.05); there was no correlation in CAL among groups before surgery 
Intra-group comparison demonstrated significant differences in all three groups before and after 
surgery (P<0.001). A statistically significant difference was found in radiographic indices among 
the groups post-surgery (P=0.009). 
Conclusion: The use of PRGF was associated with improvements in all parameters but not for GI. 
Keywords: Periodontitis, Periodontium , Plasma 
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یناوختسا تاعیاض نامرد رد ذشر روتکاف زا ینغ یامسلاپ زا هدافتسا ریثات هس هراوید ی لاتندویرپ  
 
نایبانج رفولین ،روپراجوب میرم*یرفخ ایرث ،رف یناقح انیس ،   
هذیکچ 
مذقمه: یه تفاب لهاک یزاسزاب لاتًدَیرپ ىاهرد لآ ُذیا فذّشٍر ِک ذشاب ذشر رَتکاف زا یٌغ یاوسلاپ لثه َیتارًشر یاّ
(PRGF)  .ذٌک یه لابًد ار فذّ يیا 
شور و داوم اه: ِعلاطه کی رد،یفداصت یٌیلاب ییاهزآراک ی 02 ِعیاضُراَید ِس اب یًاَختسا ی  زا یلاتًدَیرپ5 رپ اب راویب تیتًدَی
 ٍ ىاهذیربد مٍد ٍُرگ رد ،ییاٌْت ِب ىاهذیربد لرتٌک ٍُرگ رد .ذًذش نیسقت ٍُرگ ِس ِب یفداصت رَط ِب طسَته
cenomembrane ىاهذیربد زا ذعب مَس ٍُرگ رد ٍPRGF ، cenomembrane  ذح ،تکاپ گٌیبٍرپ قوع .ذش ُدرب راکب
کیفارگَیدار ٍ یا ِثل سکذًا ،یکیٌیلک یگذٌبسچ جید اب( ٍ اذتبا رد )يشکرتباس لاتی6 ُزاذًا ،ذعب ُاه یسررب یارب .ذش یریگ
.ذیدرگ ُدافتسا یاک عبره ٍ ىَسکاکلیٍ تست بیترت ِب یفیک ٍ یوک یاّریغته 
اه هتفای: ِوّ ردِثل سکذًا سج ِب ُذش رکر یاّرتهاراپ  رد دَبْب اّ ٍُرگ ییٌعه طابترا ،یٍّرگ ىٍرد ِسیاقه رد .ذش ُذید یا-
 یرادٍُرگ ِوّ رد یحارج زا ذعب ٍ لبق یکیٌیلک یگذٌبسچ ذح يیب( ذش ُذید اّP<0.05 یگذٌبسچ ذح ظاحل زا ٍُرگ ِس يیب اها .)
 یحارج زا لبق یکیٌیلک یطابتراذشً ُذید یحارج زا ذعب ٍ  لبق تکاپ گٌیبٍرپ قوع رد ٍُرگ ِس يیب یراد یٌعه طابترا .ذشً تفای.  
اها رد  یٍّرگ ىٍرد ِسیاقهرایٌعه طابتىاشً ٍُرگ ِس رد تکاپ قوع درَه رد یحارج زا ذعب ٍ لبق یراد ُداد ذش (P<0.001 .)
یٌعه یراهآ فلاتخاصخاش رد یرادٍُرگ يیب یفارگَیدار یاّ( ذش تفای یحارج لوع زا ذعب ،اّ0.009=P.) 
:یریگ هجیتن PRGF سکذًا سج ِب ُذش یریگ ُزاذًا یاّرتهاراپ یهاوت رد یدَبْب ببس .دَشیه یا ِثل 
:یذیلک ناگژاو تیتًدَیرپ ،مَیشًدَیرپ، اوسلاپ 
 
Introduction 
Angular intrabony defects are a sign of periodontal 
disease progression.
 
To date, many techniques including 
resective and regenerative procedures have been 
suggested for treating periodontal intrabony defects. 
Resective techniques eliminate granulation tissue, but 
do not regenerate periodontium. The goal of periodontal 
treatment is to regenerate the damaged periodontal 
structures.
[1]
 Many studies indicate that the growth 
factors affect proliferation, chemotaxis, cell 
differentiation and synthesis of extracellular matrix, as 
well as the vital cells involved in wound healing, and 
have a role in both periodontal healing and 
regeneration.
[2, 3]
  
Biologically active endogenous proteins offer a new 
approach to tissue regeneration. In 1999, Anitua
[2]
  
described a new technique for preparing plasma rich in 
growth factors (PRGF).
 
This 100% autologous 
preparation is enriched with biological mediators that 
accelerate regeneration of both hard and soft tissues.  
Unlike platelet-rich fibrin (PRF), it contains no  
 
leukocytes or inflammatory products,
[2]
 adhesive 
proteins such as fibrinogen, fibronectin and 
thrombospondin-1. These act as scaffold materials and 
attract platelets and undifferentiated cells. The platelets 
provide growth factors such as platelet-derived growth 
factor (PDGF), transforming growth factor-ᵝ (TGF-ᵝ) 
vascular endothelial growth factor (VEGF),  fibroblast 
growth factor (FGF), insulin-like growth factor (IGF) 
and granulocyte-macrophage colony stimulating factor 
(GM-CSF).
[3]
  
In vitro studies suggest that PRGF initiates 
fibroblasts proliferation
[4]
 and promotes wound healing 
in epithelial tissue,
[5]
 tendons and muscles.
[6]
 Other 
studies demonstrate a positive effect of PRGF on bone 
maturation
 
.
[7]
 Thorat et al. used PRF to treat intrabony 
defects, and found that it has improved the periodontal 
regeneration 
[8]
, which is similar to that of Sharma et al. 
[9]
 Yilmaz et al. applied PRGF for mandibular intrabony 
defects, and observed a reduction in probing pocket 
depth (PPD), an increase in clinical attachment level 
and bone gain.
[10]
 Del Fabbro et al. showed that using 
platelet-rich plasma (PRP) in periodontal lesions, in 
combination with graft material, has an augmented 
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effect on bone healing, but not in guided-tissue 
regeneration (GTR) procedures.
[11]
  
Taking into account the known effects of PRGF on 
hard tissue healing, this study aimed to evaluate the 
treatment in periodontal three-walled intrabony defects. 
 
 
Materials & Methods 
Case selection: This randomized clinical trial was 
approved by ethics committee of Babol Medical 
University (Grant No. 1395159 and ethics number 
mubabol.rec.1395.159). We selected 20 three-walled 
intrabony defects from 5 patients with moderate 
periodontitis. The procedure and rationale were 
explained to the patients and their informed consent was 
obtained. 
Inclusion and exclusion criteria: Patients were 
selected if they had a three-walled intrabony defect on 
the buccal or lingual side of an upper or lower first or 
second premolar or molar.  
Exclusion criteria were: any diagnosed systemic 
disorders, requirement for prophylactic antibiotics to 
prevent bacterial endocarditis, taking drugs that 
interfere with periodontal wound healing; smoking, any 
periodontal surgery contraindication, teeth with 
anatomical complications (e.g. cervical enamel 
projections), bifurcation ridges, accessory canal and 
concavity, hemi-septal bony defects, caries in the roots 
of teeth adjacent to intrabony defects, abnormal blood 
clotting times or cell blood counts, and uncooperative 
patients. All patients completed a questionnaire to 
determine whether they had a systemic disease that 
might affect bone healing, and they underwent 
periapical radiographs to detect any accessory canal.  
Intervention: Patients with defects were randomly 
allocated to three groups .The defects were not 
necessarily bilateral or in the same patient. Lesion 
debridement was used in the control group (Group 1). 
The first treatment group (Group 2) underwent 
debridement of lesions and placement of collagenous 
endomembrane. The second treatment group (Group 3) 
underwent debridement, application of PRGF gel, and 
placement of collagenous endomembrane. Surgery was 
performed on different lesions, regardless of whether 
they were bilateral or unilateral or in the same patient or 
different patients. While the initial aim was for an equal 
number of defects in each group, the final sample 
comprised a control group with seven lesions, a first 
treatment group with six lesions, and a second treatment 
group with seven. 
Clinical parameters: These parameters were: VCAL 
(distance between the CEJ [cemento-enamel junction] to 
the gingival sulcus),
 
VPD (distance between the free 
gingival margin to the gingival sulcus), and GI (Silness 
and Loe index).
 [12]
 
Preoperative preparation: Intrabony defects were 
detected by panoramic radiography, and were  more 
accurately detected after flap reflection using a surgical 
curette. Clinical parameters were measured 
preoperatively and 6 months post-surgery using a 
Williams probe (Hu-friedy-Chicago IL, USA). 
Preparation of PRGF: A few minutes before surgery, 
20ml
 
of blood was drawn from each patient and 
transferred to 5ml test tubes containing 3.8% sodium 
citrate as anticoagulant. The tubes were centrifuged at 
460 rpm for 8 minutes in a digital device (PRGF-
Endoret Technology System IV, BTI Biotechnology 
Institute, Minano, Alva, Spain). The separated samples 
comprised: layer 1, containing 1ml of plasma containing 
small amounts of growth factor; layer 2 (PGF layer), 
containing almost twice as much as layer 1 
accumulation of growth factors; layer 3 (PRGF layer), 
containing 0.5ml plasma containing various growth 
factors; layer 4 (buffy coat layer) containing 0.5 ml of 
white blood cells; layer 5, containing red blood cells.  
Layers 1 and 2 were separated with a 500-microliter 
pipette. Layer 3 (PRGF) was separated using a 100-
microliter pipette in five small aliquots, to prevent 
contamination from layer 4. Then, 50-microliter calcium 
chloride (10%) was added for every ml of PRGF to 
activate the growth-factor-rich plasma.  
Surgical procedure: Patients were anaesthetized with 
lidocaine 2% containing 1:80000 epinephrine using an 
infiltration technique. Intrasulcular incision was 
followed by full-thickness flap reflection, debridement 
of granulation tissue, and scaling and root planning. 
Without changing the intrabony architecture, the lesions 
were rinsed with normal saline and the treatment was 
carried out. All lesions were free from furcation 
involvement. All 20 lesions were undergone surgical 
flap procedures. Group 1 then received debridement 
only. Group 2 underwent debridement and placement of 
a 2x2 mm2 bioresorbable non-cross-linked collagenous 
cenomembrane (TRC cenomembrane and collagen pad, 
Diomem, Tehran, Iran), which covered the lesions, 
extending by 1mm beyond the defect margins. In group 
3, lesions were fully filled with PRGF gel and covered 
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in the same manner by membrane. Flap adaptation and 
suturing were performed with 3-0 Vicryl suture (SUPA, 
Tehran, Iran). All procedures were carried out by the 
same surgeon.  
Postsurgical procedures: Patients were instructed to 
use 0.12% chlorhexidine mouth rinse twice daily for 4 
weeks, and were prescribed with 400mg ibuprofen and 
500mg amoxicillin three times daily for 7 days. They 
were followed-up for 8 weeks, attending once a week 
for teeth polishing with a rubber cap. In the maintenance 
sessions, any supragingival plaque was removed and 
oral hygiene instructions were reinforced. After 6 
months post-surgery, the patients returned for 
measurement of the clinical parameters. 
Radiographic procedures:  
The first images were taken under standard conditions 
using a parallel technique with a digital size 2 PSP 
sensor (Soredex, Helsinki, Finland) and RinnDentsply 
film holder (Ltd, Weybridge, England, UK). A 
perforated bite block was filled with duralay impression 
material (Reliance Dental Mfg company, Chicago, 
USA) to record the occlusion. After scanning using PCT 
(Soredex, Helsinki, Finland) and the DFW 2.5)Digora 
for windows( program, radiographic images were 
processed, and stored on the computer. The same bite 
block was used pre- and post-surgery to ensure the same 
vertical and horizontal angulations were imaged. A size 
2 phosphor plate was used, with similar KVP 
[Kilovoltage peak], mA [milliamperage] and exposure 
time as the first series. The initial and post-treatment 
images were digitally subtracted in Photoshop CS6 
[Adobe Photoshop cc/2015.5.0 Release, San Jose, 
California] 
Statistical analysis: Results were recorded in mean ± 
standard deviation (median) format. Kruskal-Wallis and 
Wilcoxon signed ranks tests were used for analysis of 
quantitative variables. For qualitative variables, Chi-
square test was used. Data were analyzed using SPSS23 
(SPSS-Chicago,USA) with a two-tailed statistically 
meaningful range of P<0.05. 
 
 
Results 
A total of 20 intrabony lesions were examined (7, 6 
and 7 in the control group, first treatment group and 
third [PRGF] group, respectively). The control group 
comprised 2 male and 2 female (age 42.85±6.16 years), 
who underwent debridement only; the second group, 1 
man and 2 women (45.72±3.13 years), who underwent 
debridement and placement of a collagenous 
cenomembrane; the third group was 2 women (41.4±1.1 
years) who underwent debridement, placement of PRGF 
gel and the same membrane. Intra-group comparison of 
PPD demonstrated a significant decrease in all three 
groups before and after surgery (P<0.001) However, 
inter-group comparison of PPD revealed no correlation 
either before or after surgery. (Table 1) 
Gingival score increases by one score in all groups.  
Intra-group comparison of CAL demonstrated 
significant increase in all groups before and after 
surgery (P<0.05) (Table 2). However, inter-group 
comparison of CAL revealed no correlation whether 
before or after. A statistically significant difference was 
found between radiographic indices in the groups  post-
surgery (P=0.009) (Table 3). 
 
Table 1. Mean pocket depth (PPD) before and 6 months after surgery 
 
Groups  Pre-treatment PPD (mm) Post-treatment PPD (mm) P-value∗∗
 
PPD difference (DIFF
¥)
 
1(n=56) 2.25±1.60 (2.00) 1.89±0.88 (2.00) <0.001 -0.62±0.92 ( 0.00 )  
2(n=48) 3.10±2.00 (3.00) 2.00±0.85 (2.00) <0.001 -1.10±1.41 (-1.0 ) 
3(n=56) 2.84±1.51 (2.00) 2.21±0.75 (2.00) <0.001 -0.62±1.41 (0.00) 
P-value∗
 
0.251 0.069 - 0.090 
Numbers in the table are mean ± standard differentiation (median)  ∗Kruskal-Wallis test          ∗∗Wilcoxon signed ranks test 
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Table 2. Mean clinical attachment levels (CLA) before and at 6 months post-surgery. 
Groups Pre-treatment CLA Post-treatment CLA P-value∗∗
 
CLA difference (DIFF
¥
)
 
1(n=12) 2.21±0.80(2.0) 3.21±0.80(3.0) 0.002 1.0±0.67(1.0) 
2(n=12) 2.16±0.38(2.0) 2.91±0.28(3.0) 0.003 0.75±0.45(1.0) 
3(n=14) 2.21±0.69(2.0) 3.14±0.66(3.0) <0.001 0.92±0.26(1.0) 
P-value∗
 
0.947 0.478 - 0.180 
Numbers in the table are mean ± standard differentiation (median) ∗Kruskal-Wallis test         ∗∗Wilcoxon signed ranks test 
 
Table 3. Bone changes (radiographic indices) in the three treatment groups 
 Frequency of no change in bone (%) Frequency of bone loss (%) P-value∗ 
Group 1  6(85.7) 1(14.3)  
0.009 Group 2 1(16.7) 5(83.3) 
Group 3 1(14.3) 6(85.7) 
 
 
Discussion 
Six months after surgery, all groups showed 
improvements in PPD and CLA, but not GI. There was 
a reduction in PPD and an increase in CLA in all 
treatment modalities performed although statistically 
significant results were achieved in the control group. 
Previous study have presented that the aggregation of 
platelets occurs in a small volume of plasma.
 [13]
 As a 
result, PRP contains high concentrations of PDGF and 
TGF-ᵝ; the former initiates periodontal ligament cells, 
and the latter initiate’s osteoblast proliferation and 
differentiation. It has been shown that PRP can release 
these growth factors in damaged periodontal sites and 
influences both wound healing and regeneration.
 [13]
  
One of the key stages of PRP preparation is to 
centrifuge whole blood and separate its components into 
layers. Weibrich et al.pointed out the low efficiency of 
single-spin centrifuges,
[14]
 using in this study, and other 
more recent studies have found that dual-spin 
centrifuges (e.g. Harvest Tec [Biotech]) are more 
effective at extracting growth factors . This may be one 
reason for the lack of bone formation in the present 
study. In order to fully evaluate the regenerative 
treatments, we used digital subtraction radiography 
(DSR). Christgau et al. 
[15]
 also used DSR to examine 
bone density in intrabony lesions. They found a 
statistically significant increase (P<0.05) in bone 
density in both treatment GTR and PRGF and control  
groups. 
In the current study, there was a statistically 
significant difference in radiographic indices between 
groups, but most of the intrabony lesions in Group 1 and 
Group 3 showed no change in radiodensity or bone loss. 
The sample size in our study was small, which may  
 
explain the lack of bone formation in the PRGF group 
(Group 2). In the study by Christago et al.
 
bone 
formation was seen 12 months post-surgery in a control 
group, but the difference between the control and 
treatment groups was not statistically different. The 
authors concluded that PRGF only accelerates bone 
maturation in the early months following surgery, and 
has no significant effect on the final stages of bone 
formation.
 [15]
  
Our evaluations were only conducted at 6 months 
post-surgery, and lesions were not examined after 12 
months, which is significant given that bone formation 
is only radiographicaly detectable after 6-12 months. In 
many studies which evaluate the effect of PRGF on 
bone regeneration, PRGF was used in combination with 
autografts. This results in transportation of vital cells in 
the defect,
 [16-18]
 and tissue regeneration only occurs in 
sites with vital cells, affected by signaling molecules 
such as growth factors.
 [19]
 It is assumed that the vital 
cells surrounding the intrabony lesion provide sufficient 
cells for the growth factors in PRGF; therefore, no 
additional bone materials or auto grafts were used. For 
future studies, it is recommended to evaluate the effect 
of PRGF in combination with autografts.  
The small sample size of 20 intrabony lesions in this 
study may be the reason of why there was no 
statistically significant correlation between the groups 
for measures of CAL and PPD before or after surgery.  
A larger sample size is recommended for future studies. 
The DSR technique also has several limitations. The 
two images to be subtracted should be taken at the same 
angle (KVP and MA). Further, the technique depends 
on visual discrimination alone, which may involve 
observer error. Ravi et al. (2017) conducted a split-
mouth randomized controlled clinical trial to study the 
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effect of PRGF and GTR in the treatment of intrabony 
defects in patients with chronic periodontitis. They 
concluded that this treatment combination, as well as 
using GTR alone, improved clinical and radiographic 
parameters in these patients after 6 months. There was 
no additive effect of PRGF when combined with GTR 
to treat intrabony defects in patients with chronic 
periodontitis, in terms of either clinical or radiologic 
outcomes.
[20]
 In contrast, all the groups in the current 
study showed improvements in CAL after surgery 
(P<0.05). Similarly, PPD significantly improved in all 
three groups before and after surgery (P<0.001), and 
there was no correlation between groups before or after 
surgery (P=0.251) (P=0.069). A statistically significant 
difference was also observed in radiographic indices in 
all groups (P=0.009). These results indicate that CAL 
and PPD is improved regardless of the treatment 
modifications and even simple debrident will improve 
periodontal conditions. 
 
 
Conclusion 
PRGF resulted in improvements in all examined 
parameters except for radiographic indices and GI. 
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